Evidence map›Paper›PMID 30511024›Full record

ArticleClinical and translational radiation oncology2019

Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model.

Cheng Zhou, Bleddyn Jones, Mahmoud Moustafa, Bing Yang, Stephan Brons, Liji Cao, Ying Dai, Christian Schwager, Ming Chen, Oliver Jaekel and 3 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

Cheng ZhouDepartment of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Bleddyn JonesGray Laboratory, CRUK/MRC Oxford Oncology Institute, Radiation Oncology, University of Oxford, Oxford, UK.
Mahmoud MoustafaGerman Cancer Consortium (DKTK), Translational Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bing YangPhysics Institute University of Heidelberg, Heidelberg, Germany.
Stephan BronsHeidelberg Ion-Beam Therapy Centre (HIT), Department of Radiation Oncology, University of Heidelberg Medical School, Heidelberg, Germany.
Liji CaoDivision of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ying DaiGerman Cancer Consortium (DKTK), Translational Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Christian SchwagerGerman Cancer Consortium (DKTK), Translational Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ming ChenZhejiang Key Lab of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Oliver JaekelHeidelberg Ion-Beam Therapy Centre (HIT), Department of Radiation Oncology, University of Heidelberg Medical School, Heidelberg, Germany.
Longhua ChenDepartment of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Juergen DebusGerman Cancer Consortium (DKTK), Translational Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Amir AbdollahiGerman Cancer Consortium (DKTK), Translational Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heidelberg University · DEUniversity Hospital Heidelberg · DEAnhui Medical University · CNCRUK/MRC Oxford Institute for Radiation Oncology · GBGerman Cancer Research Center · DEHeidelberger Institut für Radioonkologie · DENanfang Hospital · CNZhejiang Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposesCarbon ion radiotherapy (CIRT) with raster scanning technology is a promising treatment for lung cancer and thoracic malignancies. Determining normal tissue tolerance of organs at risk is of utmost importance for the success of CIRT. Here we report the relative biological effectiveness (RBE) of CIRT as a function of dose and fractionation for development of pulmonary fibrosis using well established fibrosis index (FI) model. MATERIALS AND

methodsDose series of fractionated clinical quality CIRT versus conventional photon irradiation to the whole thorax were compared in C57BL6 mice. Quantitative assessment of pulmonary fibrosis was performed by applying the FI to computed tomography (CT) data acquired 24-weeks post irradiation. RBE was calculated as the ratio of photon to CIRT dose required for the same level of FI. Further RBE predictions were performed using the derived equation from high-linear energy transfer biologically effective dose (high-LET BED) model.

resultsThe averaged lung fibrosis RBE of 5-fraction CIRT schedule was determined as 2.75 ± 0.55. The RBE estimate at the half maximum effective dose (RBE

conclusionThis is the first report of RBE estimation for CIRT with the endpoint of pulmonary fibrosis

Indexed as

BED, biologically effective doseBiologically effective dose (BED)Carbon ion radiotherapy (CIRT)CPFE, combined pulmonary fibrosis and emphysema syndromeCT, computed tomographyFI, fibrosis indexFractionationHigh-linear energy transfer (high-LET)HU, Hounsfield unitLET, linear energy transferLQ model, linear quadratic modelLung fibrosisNormal tissue responseNSCLC, non-small cell lung cancerPMMA, PolymethylmethacrylatRBE, relative biological effectivenessRelative biological effectiveness (RBE)RILF, Radiation-induced lung fibrosisRP, radiation pneumonitisSBRT or SABR, hypofractionated stereotactic body or ablative radiation therapyV5, volume of lung receiving ≥5 Gy (RBE)α/β, alpha/beta ratio

Identifiers

PMID30511024
PMCPMC6257927
OpenAlexW2898731306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.